References

  1. Ford N, Darder M, Spelman T, Maclean E, Mills E, Boulle A. Early adherence to antiretroviral medication as a predictor of long-term HIV virological suppression: five-year follow up of an observational cohort. PLoS ONE. 2010; 5(5): 3-6. PubMed | Google Scholar

  2. Bangsberg DR. Less than 95% adherence to non-nucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression. Clin Infect Dis. 2006 Oct; 43(7): 939-41. PubMed | Google Scholar

  3. Mannheimer SB, Morse E, Matts JP, Andrews L, Child C, Schmetter B et al. Sustained benefit from a long-term antiretroviral adherence intervention; results of a large randomized clinical trial. J Acquir Immune Defic Syndr. 2006; 43 Suppl 1: S41-S47. PubMed | Google Scholar

  4. Paterson DL, Swindells S, Mohr J, Brester M, Vergis EN, Squier C et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000 Jul 4; 133(1): 21-30. PubMed | Google Scholar

  5. Langebeek N, Gisolf EH, Reiss P, Vervoort SC, Hafsteinsdóttir TB, Richter C et al. Predictors and correlates of adherence to combination antiretroviral therapy (ART) for chronic HIV infection: a meta-analysis. 2014 Aug 21; 12: 142. PubMed | Google Scholar

  6. Reda AA, Biadgilign S. Determinants of Adherence to Antiretroviral Therapy among HIV-Infected Patients in Africa. AIDS Res Treat. 2012; 2012: 574656. PubMed | Google Scholar

  7. Katz IT, Ryu AE, Onuegbu AG, Psaros C, Weiser SD, Bangsberg DR et al. Impact of HIV-related stigma on treatment adherence: systematic review and meta-synthesis. J Int AIDS Soc. 2013; 16(3 Suppl 2). PubMed | Google Scholar

  8. Heestermans T, Browne JL, Aitken SC, Vervoort SC, Klipstein-Grobusch K. Determinants of adherence to antiretroviral therapy among HIV-positive adults in sub-Saharan Africa: a systematic review. BMJ Glob Health. 2016; 1(4): e000125. PubMed | Google Scholar

  9. Desclaux A, Ciss M, Taverne B, Sow PS, Egrot M, Faye MA et al. Access to antiretroviral drugs and AIDS management in Senegal. AIDS. 2003; 17(Suppl 3): S95-101. PubMed | Google Scholar

  10. Conseil National de Lutte Contre le SIDA (CNLS). Rapport de situation sur la riposte nationale a l'épidemie de VIH/SIDA/Senegal:2015-2016. SEN_narrative_report_2015.pdf. Accessed May 30 2017.

  11. UNAIDS. 90-90-90: An ambitious treatment target to help end the AIDS epidemic. Accessed May 30 2017.

  12. Etard J-F, Lanièce I, Fall M, Cilote V, Blazejewski L, Diop K et al. A 84-month follow up of adherence to HAART in a cohort of adult Senegalese patients. 2007; 12(10): 1191. PubMed | Google Scholar

  13. Laniece I, Ciss M, Desclaux A, Diop K, Mbodj F, Ndiaye B et al. Adherence to HAART and its principal determinants in a cohort of Senegalese adults. AIDS. 2003; 17(Suppl 3): S103-S108. PubMed | Google Scholar

  14. Bastard M, Fall MB; groupe d’étude de la Cohorte ANRS 1215. Long term adherence to HAART in Senegal. Bull Soc Pathol Exot. 2014; 107(4): 241-243. PubMed

  15. Sow PG, Toure K, Coume M, Dia AT, Traore I. Predictors of ART adherence among HIV infected individuals in Dakar Senegal. J Med Sci. 2012; 3(4): 212-216. Google Scholar

  16. Bain LE, Nkoke C, Noubiap JJN. UNAIDS 90-90-90 targets to end the AIDS epidemic by 2020 are not realistic: comment on "Can the UNAIDS 90-90-90 target be achieved: a systematic analysis of national HIV treatment cascades. BMJ Glob Health. 2017 Mar 7; 2(2): e000227. PubMed | Google Scholar

  17. Woodward M. Epidemiology: Study design and Data Analysis. Third Edit, Florida: Chapman and Hall/CRC. 2013. Google Scholar

  18. Steel Gavin, Nwokike Jude, Joshi MP. Development of a Multi-Method Tool to Measure ART Adherence in Resource-Constrained Settings: The South Africa Experience 2007. Accessed May 30 2017.

  19. Knobel H, Alonso J, Casado JL, Collazos J, González J, Ruiz I et al. Validation of a simplified medication adherence questionnaire in a large cohort of HIV-infected patients: the GEEMA Study. AIDS Lond Engl. 2002; 16(4): 605-13. PubMed | Google Scholar

  20. Williams AB, Amico KR, Bova C, Womack JA. A proposal for quality standards for measuring medication adherence in research. AIDS Behav. 2013 Jan 1; 17(1): 284-97. PubMed | Google Scholar

  21. Evans D, Fox MP. When and how should we be measuring adherence to antiretroviral therapy in resource-limited settings. J Clin Res HIV AIDS Prev. 2013; 1(2): 24-30. Google Scholar

  22. Mills EJ, Nachega JB, Bangsberg DR, Singh S, Rachlis B, Wu P et al. Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators. PLoS Med. 2006 Nov 21; 3(11): e438. PubMed | Google Scholar

  23. Buregyeya E, Naigino R, Mukose A, Makumbi F, Esiru G, Arinaitwe J et al. Facilitators and barriers to uptake and adherence to lifelong antiretroviral therapy among HIV infected pregnant women in Uganda: a qualitative study. BMC Pregnancy Childbirth. 2017 Dec; 17: 94 Google Scholar

  24. UNAIDS. Global AIDS. 2016. Accessed May 30 2017.

  25. McMahon JH, Elliott JH, Bertagnolio S, Kubiak R, Jordan MR. Viral suppression after 12 months of antiretroviral therapy in low- and middle-income countries: a systematic review. Bull World Health Organ. 2013 May 1; 91(5): 377-385E. PubMed | Google Scholar

  26. Berg KM, Arnsten JH. Practical and conceptual challenges in measuring antiretroviral adherence. J Acquir Immune Defic Syndr. 2006 Dec 1; 43 Suppl 1: S79-87. PubMed | Google Scholar

  27. Haberer JE, Sabin L, Amico KR, Orrell C, Galárraga O, Tsai AC et al. Improving antiretroviral therapy adherence in resource-limited settings at scale: a discussion of interventions and recommendations: Haberer JE et al. J Int AIDS Soc. 2017; 20(1): 21371.. PubMed | Google Scholar

  28. Luque-Fernandez MA, Van Cutsem G, Goemaere E, Hilderbrand K, Schomaker M, Mantangana N et al. Effectiveness of Patient Adherence Groups as a Model of Care for Stable Patients on Antiretroviral Therapy in Khayelitsha, Cape Town, South Africa. PLoS ONE. 2013 Feb 13; 8(2): e56088. PubMed | Google Scholar

  29. Burch LS, Smith CJ, Anderson J, Sherr L, Rodger AJ, O'Connell R et al. Socioeconomic status and treatment outcomes for individuals with HIV on antiretroviral treatment in the UK: cross-sectional and longitudinal analyses. Lancet Public Health. 2016 Nov; 1(1): e26-36. PubMed | Google Scholar

  30. Nachega JB, Uthman OA, Peltzer K, Richardson LA, Mills EJ, Amekudzi K et al. Association between antiretroviral therapy adherence and employment status: systematic review and meta-analysis. Bull World Health Organ. 2015 Jan 1; 93(1): 29-41. PubMed | Google Scholar

  31. Esther B, Rose N, Aggrey M, Fred M, Godfrey E, Jim A et al. Facilitators and barriers to uptake and adherence to lifelong antiretroviral therapy among HIV infected pregnant women in Uganda: a qualitative study. BMC Pregnancy Childbirth. 2017; 17: 94. PubMed | Google Scholar

  32. Chime OH, Arinze-Onyia SU, Obionu CN. Do peer support groups influence medication adherence: a study among people living with HIV/AIDS in Enugu State, Nigeria. Proc Singap Healthc. 2018 Mar 4; 27(4). Google Scholar

  33. Ware NC, Wyatt MA, Tugenberg T. Social relationships, stigma and adherence to antiretroviral therapy for HIV/AIDS. AIDS Care. 2006 Nov 1; 18(8): 904-10. PubMed | Google Scholar

  34. Paterson DL, Swindells S, Mohr J, Brester M, Vergis EN, Squier C, Wagener MM, Singh N. Adherence to anti-HIV therapy and the outcome of treatment. Ann Intern Med. 2000 Jul 4; 133(1): 21.